Miniature type V-F CRISPR-Cas nucleases enable targeted DNA modification in cells

Greta Bigelyte(Vilnius University), Joshua K. Young(Corteva (United States)), Tautvydas Karvelis(Vilnius University), Karolina Budre(Vilnius University), Rimantė Žedaveinytė(Vilnius University), Vesna Djukanovic(Corteva (United States)), Elizabeth Van Ginkel(Corteva (United States)), Sushmitha Paulraj(Corteva (United States)), Stephen L. Gasior(Corteva (United States)), Spencer Jones(Corteva (United States)), Lanie Feigenbutz(Corteva (United States)), Grace St. Clair(Corteva (United States)), Pierluigi Barone(Corteva (United States)), Jennifer Bohn(Corteva (United States)), Ananta Acharya(Corteva (United States)), Gina Zastrow‐Hayes(Corteva (United States)), Selgar Henkel-Heinecke(Leipzig University), Arūnas Šilanskas(Vilnius University), Ralf Seidel(Leipzig University), Virginijus Šikšnys(Vilnius University)
Nature Communications
October 26, 2021
Cited by 119Open Access
Full Text

Abstract

Class 2 CRISPR systems are exceptionally diverse, nevertheless, all share a single effector protein that contains a conserved RuvC-like nuclease domain. Interestingly, the size of these CRISPR-associated (Cas) nucleases ranges from >1000 amino acids (aa) for Cas9/Cas12a to as small as 400-600 aa for Cas12f. For in vivo genome editing applications, compact RNA-guided nucleases are desirable and would streamline cellular delivery approaches. Although miniature Cas12f effectors have been shown to cleave double-stranded DNA, targeted DNA modification in eukaryotic cells has yet to be demonstrated. Here, we biochemically characterize two miniature type V-F Cas nucleases, SpCas12f1 (497 aa) and AsCas12f1 (422 aa), and show that SpCas12f1 functions in both plant and human cells to produce targeted modifications with outcomes in plants being enhanced with short heat pulses. Our findings pave the way for the development of miniature Cas12f1-based genome editing tools.


Related Papers

No related papers found

Powered by citation graph analysis